Dopamine inhibits mammalian photoreceptor Na+,K+-ATPase activity via a selective effect on the α3 isozyme

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 15, 1996, Pages 8034-8039

  Shulman, Lanny M ^a   Fox, Donald A ^a,b  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

neurotransmitters; oxygen consumption; retina; rods

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DOPAMINE RECEPTOR; FENOLDOPAM; KYNURENIC ACID; QUINPIROLE;

ANIMAL CELL; ARTICLE; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; ENZYME ACTIVITY; HYPOTHESIS; NEUROTRANSMISSION; NONHUMAN; OXYGEN CONSUMPTION; PHOTORECEPTOR; PRIORITY JOURNAL;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; AMINOBUTYRIC ACIDS; AMPHETAMINE; ANIMALS; CLOZAPINE; DARKNESS; DOPAMINE; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID AGONISTS; FEMALE; ISOENZYMES; KYNURENIC ACID; LIGHT; NA(+)-K(+)-EXCHANGING ATPASE; OUABAIN; OXYGEN CONSUMPTION; PHOTORECEPTORS; RATS; RETINA; ROD OUTER SEGMENTS; RODS (RETINA);

ANIMALIA; MAMMALIA; STROPHANTHUS GRATUS;

EID: 0029842869     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.15.8034     Document Type: Article

References (51)

1. Stahl, W. L. (1986) Neurochem. Int. 4, 449-476.
2. Hagins, W. A. (1972) Annu. Rev. Biophys. Bioeng. 1, 131-157.
3. Sweadner, K. J. (1989) Biochim. Biophys. Acta 989, 185-220.
4. McGrail, K. M. & Sweadner, K. J. (1989) Eur. J. Neurosci. 2, 170-176.
5. Schneider, B. G. & Kraig, E. (1990) Exp. Eye Res. 51, 553-564.
6. Schneider, B. G., Shygan, A. W. & Levenson, R. (1991) J. Histochem. Cytochem. 39, 507-517.
7. Torre, V. (1982) J. Physiol. (London) 333, 315-341.
8. Shimazaki, H. & Oakley, B., II (1984) J. Gen. Physiol. 84, 475-504.
9. Winkler, B. S. & Riley, M. V. (1977) Invest. Ophthalmol. Visual Sci. 16, 1151-1154.
10. Winkler, B. S. & Riley, M. V. (1980) Invest. Ophthalmol. Visual Sci. 19, 562-564.
11. Fox, D. A., Rubinstein, S. D. & Hsu, P. (1991) Toxicol. Appl. Pharmacol. 109, 482-493.
12. Bertorello, A. M., Hopfield, J. F., Aperia, A. & Greengard, P. (1990) Nature (London) 347, 386-388.
13. Aperia, A., Bertorello, A. M. & Seri, I. (1987) Am. J. Physiol. 252, F39-F45.
14. Chen, C. & Lokhandwala, M. (1993) Arch. Pharmacol. 347, 289-295.
15. Seri, I., Kone, B. C., Gullans, S. R., Aperia, A., Brenner, B. M. & Ballermann, B. J. (1988) Am. J. Physiol. 255, F666-F673.
16. Djamgoz, M. B. A. & Wagner, H.-J. (1992) Neurochem. Int. 20, 139-191.
17. Witkovsky, P. & Dearry, A. (1992) Prog. Retinal Res. 11, 247-292.
18. Ehinger, B. (1982) Retina 2, 305-321.
19. Nguyen-Legros, J. Moussafi, F. & Simon, A. (1990) Visual Neurosci. 4, 547-553.
20. Witkovsky, P., Nicholson, C., Rice, M. E., Bohmaker, K. & Meller, E. (1993) Proc. Natl. Acad. Sci. USA 90, 5667-5671.
21. Dearry, A., Falardeau, P., Shores, C. & Caron, M. C. (1991) Cell. Mol. Neurobiol. 11, 437-453.
22. Cohen, A. I., Todd, R., Harmon, S. & O'Malley, K. L. (1992) Proc. Natl. Acad. Sci. USA 89, 12093-12097.
23. Wagner, H.-J., Luo, B.-G., Ariano, M. A., Sibley, D. R. & Stell, W. K. (1993) J. Comp. Neurol. 331, 469-481.
24. Cohen, A. I. & Blazynski, C. (1990) Visual Neurosci. 4, 43-52.
25. Shulman, L. M. & Fox, D. A. (1995) Invest. Ophthalmol. Visual Sci. 36, S272 (abstr.).
26. Medrano, C. J. & Fox, D. A. (1995) Exp. Eye Res. 61, 273-284.
27. Xu, X., Xu, J., Huang, B., Livsey, C. T. & Karwoski, J. (1991) Exp. Eye Res. 52, 691-698.
28. Ottlecz, A., Garcia, C. A., Eichberg, J. & Fox, D. A. (1993) Curr. Eye Res. 12, 1111-1121.
29. Haber, R. S., Pressley, T. A., Loeb, J. N. & Ismail-Beigi, F. (1987) Am. J. Physiol. 253, F26-F33.
30. Witkovsky, P. & Shi, X.-P. (1990) Visual Neurosci. 5, 405-413.
31. Bugnon, O., Ofori, S. & Schorderet, M. (1995) Arch. Pharmacol. 351, 53-59.
32. Nakatani, K., Tamura, T. & Yau, K. W. (1991) J. Gen. Physiol. 97, 413-435.
33. Lolley, R. N., Lee, R. H., Chase, D. G. & Racz, E. (1986) Invest. Ophthalmol. Visual Sci. 27, 285-295.
34. Fox, D. A. & Chu, L. W.-F. (1988) Exp. Eye Res. 46, 613-625.
35. Fox, D. A. & Rubinstein, S. D. (1989) Exp. Eye Res. 48, 237-249.
36. Yoshikami, S., Robinson, W. E. & Hagins, W. A. (1974) Science 185, 1176-1179.
37. Biernbaum, M. S. & Bownds, M. D. (1979) J. Gen. Physiol. 74, 649-669.
38. Bradford, M. M. (1986) Anal. Biochem. 72, 248-254.
39. Mandel, L. J. & Balaban, R. S. (1981) Am. J. Physiol. 240, F357-F371.
40. Hootman, S. R. & Williams, J. A. (1985) J. Physiol. (London) 360, 121-134.
41. Marks, M. J. & Seeds, N. W. (1978) Life Sci. 23, 2735-2744.
42. Fuller, R. W., Hemrick-Luecke, S. K. & Ornstein, P. L. (1992) Neuropharmacology 31, 1027-1032.
43. Hemrick-Luecke, S. K., Henderson, M. G. & Fuller, R. W. (1992) Life Sci. 50, PL31-PL33.
44. Gauchy, C., Desban, M., Glowinski, J. & Kernel, M. L. (1994) Brain Res. 635, 249-256.
45. Dixon, M. & Webb, E. C. (1979) Enzymes (Academic, New York), 3rd Ed., pp. 332-467.
46. Civelli, O., Bunzow, J. R. & Grandy, D. K. (1993) Annu. Rev. Pharmacol. Toxicol. 32, 281-307.
47. Shulman, L. M. & Fox, D. A. (1996) Invest. Ophthalmol. Visual Sci. 37, S139 (abstr.).
48. Bertorello, A. M. & Aperia, A. (1990) Am. J. Physiol. 259, F924-F928.
49. Hestrin, S. (1987) J. Physiol. (London) 390, 319-333.
50. Longoni, B., Demontis, G. C., Bisti, S., Marchiafava, P. L. & Cervetto, L. (1994) Neurosci. Abs. 20, 966 (abstr.).
51. Krizaj, D. & Witkovsky, P. (1993) Brain Res. 627, 122-128.